Jade Biosciences, Inc. (JBIO)
19.83
-1.57
(-7.34%)
USD |
NASDAQ |
Sep 03, 16:00
19.83
0.00 (0.00%)
After-Hours: 19:09
Jade Biosciences Max Drawdown (5Y) : 99.22% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 99.22% |
| July 31, 2026 | 99.22% |
| June 30, 2026 | 99.22% |
| May 31, 2026 | 99.22% |
| April 30, 2026 | 99.22% |
| March 31, 2026 | 99.22% |
| February 28, 2026 | 99.22% |
| Date | Value |
|---|---|
| January 31, 2026 | 99.22% |
| December 31, 2025 | 99.22% |
| November 30, 2025 | 99.22% |
| October 31, 2025 | 99.22% |
| September 30, 2025 | 99.22% |
| August 31, 2025 | 99.22% |
| July 31, 2025 | 99.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Perspective Therapeutics, Inc. | 93.08% |
| Cue Biopharma, Inc. | 99.01% |
| Praxis Precision Medicines, Inc. | 98.67% |
| Opus Genetics, Inc. | 99.15% |
| Faeth Therapeutics, Inc. | 98.73% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -63.31 |
| Beta (5Y) | 1.453 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.5% |
| Historical Sharpe Ratio (5Y) | -0.4991 |
| Historical Sortino (5Y) | -0.6861 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.57% |